Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.70 Analyst target: $6.75 Upside: 864.84%
Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.